Stocks and Investing
Stocks and Investing
Wed, April 17, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Reiterated (TVTX) at Buy and Held Target at $13 on, Apr 17th, 2024
Laura Chico of Wedbush, Reiterated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $13 on, Apr 17th, 2024.
Laura has made no other calls on TVTX in the last 4 months.
There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 4 agree with Laura's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vamil Divan of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, March 27th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $9 on, Friday, February 16th, 2024
- Nicole Gabreski of "Piper Sandler" Maintained at Hold with Increased Target to $11 on, Thursday, January 18th, 2024
- Alex Thompson of "Stifel" Maintained at Hold with Increased Target to $10 on, Monday, December 18th, 2023
This is the rating of the analyst that currently disagrees with Laura
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $17 on, Wednesday, March 13th, 2024
Contributing Sources